Diagnostic firm BioAffinity's shares more than double on Nasdaq debut
01/09/2022 18:09
** Cancer diagnostic maker BioAffinity Technologies Inc's
shares BIAF.O more than double to $13.8 on their Nasdaq market
debut
** Co priced its initial public offering of nearly 1.3
million units of common stock and warrants at $6.12/ unit to
raise over $7.8 mln urn:newsml:reuters.com:*:nBwMVbjVa
** Co intends to use the gross proceeds to commercialize its
non-invasive test to detect lung cancer
** BIAF develops noninvasive diagnostic tests and cancer
therapeutics
(Reporting by Khushi Mandowara)
((Khushi.Mandowara@thomsonreuters.com;))